2020
DOI: 10.3389/fnut.2020.586178
|View full text |Cite
|
Sign up to set email alerts
|

Bioactive Compounds for the Management of Hypertriglyceridemia: Evidence From Clinical Trials and Putative Action Targets

Abstract: Hypertriglyceridemia refers to the presence of elevated concentrations of triglycerides (TG) in the bloodstream (TG >200 mg/dL). This lipid alteration is known to be associated with an increased risk of atherosclerosis, contributing overall to the onset of atherosclerotic cardiovascular disease (CVD). Guidelines for the management of hypertriglyceridemia are based on both lifestyle intervention and pharmacological treatment, but poor adherence, medication-related costs and side effects can limit the suc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 140 publications
0
1
0
Order By: Relevance
“…As reported in scientific studies, polyphenols can positively influence cholesterol metabolism, especially regarding the B2 class of dimeric procyanidins [ 35 ]. Moreover, the decrease in TG levels observed in the TN treatment groups may be justified both by the reported beneficial effects exerted by polyphenols on the management of hypertriglyceridemia [ 36 ] and by the positive response of plasma TG levels resulting from improved glycemic control, as described by scientific evidence [ 37 ]. In agreement with this hypothesis, our characterization of the TN polyphenolic profile performed by a validated HPLC-DAD method [ 38 ] highlights the high potential of this matrix in terms of polyphenol content [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…As reported in scientific studies, polyphenols can positively influence cholesterol metabolism, especially regarding the B2 class of dimeric procyanidins [ 35 ]. Moreover, the decrease in TG levels observed in the TN treatment groups may be justified both by the reported beneficial effects exerted by polyphenols on the management of hypertriglyceridemia [ 36 ] and by the positive response of plasma TG levels resulting from improved glycemic control, as described by scientific evidence [ 37 ]. In agreement with this hypothesis, our characterization of the TN polyphenolic profile performed by a validated HPLC-DAD method [ 38 ] highlights the high potential of this matrix in terms of polyphenol content [ 22 ].…”
Section: Discussionmentioning
confidence: 99%